LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Chief Executive Officer Dr. Kevin Rodan will receive a Certificate of Excellence from the Ministry of Health. The recognition, expected to be presented on July 10, 2026, honors Dr. Rodan's contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement.
The award is part of Ministry of Health initiatives focused on acknowledging healthcare professionals whose work supports innovation, medical technology development, and high standards of patient care. The Company believes this recognition underscores the growing importance of healthcare technology, digital infrastructure, and innovation-focused leadership in modernizing healthcare systems throughout Latin America.
Dr. Kevin Rodan stated: “I am honored to be recognized in connection with healthcare innovation and excellence. Healthcare systems throughout Latin America continue to face significant accessibility, coordination, and infrastructure challenges, and I believe technology can play an important role in helping address those challenges. This recognition is meaningful not only personally, but also because it reflects the broader importance of innovation, collaboration, and patient-focused healthcare development.”
The Certificate of Excellence is expected to be presented during an upcoming Ministry of Health event dedicated to recognizing contributions to healthcare advancement, innovation, and excellence. The Company noted that the recognition relates to Dr. Rodan's professional contributions and does not constitute regulatory approval or endorsement of any specific product or service.
This announcement highlights the increasing recognition of digital health leaders in emerging markets. LataMed AI focuses on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled solutions, with an initial regional focus on Latin America. For more information, visit https://latamed.ai and review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Forward-looking statements in this press release involve risks and uncertainties, including the Company’s ability to execute its business plan, obtain financing, and achieve operational goals. The Company undertakes no obligation to update these statements.
